We are live on
!
Find out more
JBIO
Jade Biosciences
JBIO
JBIO
58 hedge funds and large institutions have $386M invested in Jade Biosciences in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 22 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 12
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.01% less ownership
Funds ownership: 2.95% → 2.94% (-0.01%)
2% less funds holding
Funds holding: 59 → 58 (-1)
21% less capital invested
Capital invested by funds: $488M → $386M (-$102M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
0.92%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
2
Increased
22
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$5.01M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.07M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$1.92M |
| 4 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$717K |
| 5 |
FAM
Fred Alger Management
New York
|
-$513K |
